Efficacy and safety of Tenofovir disoproxil fumarate in patients with chronic hepatitis B genotype C; Real-life practice from South Korea

Trial Profile

Efficacy and safety of Tenofovir disoproxil fumarate in patients with chronic hepatitis B genotype C; Real-life practice from South Korea

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Sep 2015

At a glance

  • Drugs Tenofovir disoproxil fumarate (Primary)
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Sep 2015 New trial record
    • 12 Sep 2015 Results published in the International Journal of Clinical Pharmacy
    • 12 Sep 2015 Results published in the International Journal of Clinical Pharmacy.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top